Correspondence 0001140361-25-010703 from Senti Biosciences, Inc. (SNTI) (CIK 0001854270) (SNTI)
Senti Biosciences, Inc. (SNTI) (CIK 0001854270)
Date: March 27, 2025 · CIK: 0001854270 · Accession: 0001140361-25-010703
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285985
Letter
Re:
Senti Biosciences, Inc. 2 Corporate Drive, First Floor South San Francisco, California 94080
March 27, 2025
VIA EDGAR
Securities and Exchange Commission Division of Corporation Finance – Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549
Senti Biosciences, Inc. Registration Statement on Form S-3 File No. 333-285985 Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Senti Biosciences, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-285985) (the “Registration Statement”), so that it may become effective at 9:00 am Eastern time on March 31, 2025, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
If you have any questions regarding this request, please contact Maggie Wong, Esq. of Goodwin Procter LLP at (415) 733-6071.
Very truly yours,
SENTI BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
Senti Biosciences, Inc.
2 Corporate Drive, First Floor
South San Francisco, California 94080
March 27, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance – Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re:
Senti Biosciences, Inc.
Registration Statement on Form S-3
File No. 333-285985
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Senti Biosciences, Inc. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement
on Form S-3 (File No. 333-285985) (the “Registration Statement”), so that it may become effective at 9:00 am Eastern time on March 31, 2025, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by
telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
If you have any questions regarding this request, please contact Maggie Wong, Esq. of Goodwin Procter LLP at (415) 733-6071.
Very truly yours,
SENTI BIOSCIENCES, INC.
By:
/s/ Timothy Lu
Name: Timothy Lu
Title: President & Chief Executive Officer
Cc: Maggie Wong, Goodwin Procter LLP
Jesse Fishman, Goodwin Procter LLP